Andrew Last compensation by year
BIO-RAD LABORATORIES Summary Compensation Table · all 5 fiscal years held| Component | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| Salary | $387,019 | $612,346 | $610,760 | $638,566 | $660,250 |
| Bonus | $50,000 | $0 | $0 | $0 | $0 |
| Stock awards | $1,496,200 | $1,892,723 | $2,063,453 | $2,249,393 | $2,587,795 |
| Option awards | $412,894 | $532,987 | $603,703 | $0 | $0 |
| Non-equity incentive | $335,023 | $871,437 | $913,453 | $457,382 | $0 |
| Pension and deferred compensation | $0 | $0 | $0 | $0 | $0 |
| All other | $53,625 | $14,659 | $20,044 | $20,794 | $22,044 |
| Total | $2,734,761 | $3,924,152 | $4,211,413 | $3,366,135 | $3,270,089 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: BIO-RAD LABORATORIES, INC. DEF 14A filed March 27, 2024, accession 0001308179-24-000313, and prior-year filings.
How this page was built: the BIO-RAD LABORATORIES, INC. filed document, accession 0001308179-24-000313. Every figure is read from that document and cited to the page and table it appears in. Filed March 27, 2024.
Equity holdings
unvested awards at FY2023 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 5,008 | $1,617,033 | — |
| RSU | 2,602 | $840,160 | — |
| RSU | 1,266 | $408,779 | — |
| RSU | 1,000 | $322,890 | — |
| RSU | 903 | $291,570 | — |
| PSU | 835 | $269,613 | — |
| PSU | 579 | $186,953 | — |
| Option | 1,000 | — | $299.24 |
| Option | 903 | — | $524.30 |
| Option | 1,266 | — | $814.95 |
Per the Outstanding Equity Awards at Fiscal Year-End table in BIO-RAD LABORATORIES, INC.'s FY2023 proxy; value at the fiscal year-end close, as the company printed it.
BIO-RAD LABORATORIES’s named executive officers, FY2023
as the company reported each| Named executive officer | Role | FY2023 total |
|---|---|---|
| Norman Schwartz | President, Chief Executive Officer and Chairman | $7,463,878 |
| Andrew Last · this page | Executive Vice President Chief Operating Officer | $3,270,089 |
| Ilan Daskal | Former Executive Vice President and Chief Financial Officer | $2,655,971 |
| Dara Grantham Wright | Executive Vice President, President, Clinical Diagnostics Group | $2,133,126 |
| Simon May | Executive Vice President, President, Life Science Group | $2,089,221 |
| Michael Crowley | Executive Vice President, Global Commercial Operations | $2,086,215 |
The full BIO-RAD LABORATORIES compensation record
free company briefThis page is one person within BIO-RAD LABORATORIES's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the BIO-RAD LABORATORIES proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are BIO-RAD LABORATORIES's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.